193 related articles for article (PubMed ID: 30383449)
1. RNA stability protein ILF3 mediates cytokine-induced angiogenesis.
Vrakas CN; Herman AB; Ray M; Kelemen SE; Scalia R; Autieri MV
FASEB J; 2019 Mar; 33(3):3304-3316. PubMed ID: 30383449
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA ILF3-AS1 facilitates hepatocellular carcinoma progression by stabilizing ILF3 mRNA in an m
Bo C; Li N; He L; Zhang S; An Y
Hum Cell; 2021 Nov; 34(6):1843-1854. PubMed ID: 34491544
[TBL] [Abstract][Full Text] [Related]
3. The RNA-binding protein ILF3 binds to transposable element sequences in SINEUP lncRNAs.
Fasolo F; Patrucco L; Volpe M; Bon C; Peano C; Mignone F; Carninci P; Persichetti F; Santoro C; Zucchelli S; Sblattero D; Sanges R; Cotella D; Gustincich S
FASEB J; 2019 Dec; 33(12):13572-13589. PubMed ID: 31570000
[TBL] [Abstract][Full Text] [Related]
4. Interleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expression.
Hu Q; Lu YY; Noh H; Hong S; Dong Z; Ding HF; Su SB; Huang S
Oncogene; 2013 Aug; 32(34):3933-43. PubMed ID: 22986534
[TBL] [Abstract][Full Text] [Related]
5. Targeting of integrin-linked kinase with small interfering RNA inhibits VEGF-induced angiogenesis in retinal endothelial cells.
Xie W; Zhao M; Zhou W; Guo L; Huang L; Yu W; Li X
Ophthalmic Res; 2013; 49(3):139-49. PubMed ID: 23258222
[TBL] [Abstract][Full Text] [Related]
6. ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer.
Li K; Wu JL; Qin B; Fan Z; Tang Q; Lu W; Zhang H; Xing F; Meng M; Zou S; Wei W; Chen H; Cai J; Wang H; Zhang H; Cai J; Fang L; Bian X; Chen C; Lan P; Ghesquière B; Fang L; Lee MH
Cell Res; 2020 Feb; 30(2):163-178. PubMed ID: 31772275
[TBL] [Abstract][Full Text] [Related]
7. E2F1-mediated KDM4A-AS1 up-regulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA.
Shen HM; Zhang D; Xiao P; Qu B; Sun YF
Cancer Gene Ther; 2023 Jul; 30(7):1007-1017. PubMed ID: 36973424
[TBL] [Abstract][Full Text] [Related]
8. EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancer.
Cheng CC; Chou KF; Wu CW; Su NW; Peng CL; Su YW; Chang J; Ho AS; Lin HC; Chen CG; Yang BL; Chang YC; Chiang YW; Lim KH; Chang YF
Lung Cancer; 2018 Feb; 116():80-89. PubMed ID: 29413056
[TBL] [Abstract][Full Text] [Related]
9. RNA binding protein POP7 regulates ILF3 mRNA stability and expression to promote breast cancer progression.
Huang Y; Zheng Y; Yao L; Qiao F; Hou Y; Hu X; Li D; Shao Z
Cancer Sci; 2022 Nov; 113(11):3801-3813. PubMed ID: 35579257
[TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV promotes keratinocyte proliferation and migration through upregulating lncRNA H19 recruited ILF3 to enhance the stability of CDK4 mRNA.
Wang DD; Zhang LZ; Pang CJ; Ye JZ
Kaohsiung J Med Sci; 2023 Aug; 39(8):811-823. PubMed ID: 37132584
[TBL] [Abstract][Full Text] [Related]
11. circACTA2 mediates Ang II-induced VSMC senescence by modulation of the interaction of ILF3 with CDK4 mRNA.
Ma Y; Zheng B; Zhang XH; Nie ZY; Yu J; Zhang H; Wang DD; Shi B; Bai Y; Yang Z; Wen JK
Aging (Albany NY); 2021 Apr; 13(8):11610-11628. PubMed ID: 33885378
[TBL] [Abstract][Full Text] [Related]
12. Double-stranded RNA-binding protein regulates vascular endothelial growth factor mRNA stability, translation, and breast cancer angiogenesis.
Vumbaca F; Phoenix KN; Rodriguez-Pinto D; Han DK; Claffey KP
Mol Cell Biol; 2008 Jan; 28(2):772-83. PubMed ID: 18039850
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of ERp57 promotes clear cell renal cell carcinoma progression by initiating a STAT3/ILF3 feedback loop.
Liu Y; Wang JX; Nie ZY; Wen Y; Jia XJ; Zhang LN; Duan HJ; Shi YH
J Exp Clin Cancer Res; 2019 Oct; 38(1):439. PubMed ID: 31747963
[TBL] [Abstract][Full Text] [Related]
14. HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.
Jiang F; Tang X; Tang C; Hua Z; Ke M; Wang C; Zhao J; Gao S; Jurczyszyn A; Janz S; Beksac M; Zhan F; Gu C; Yang Y
J Hematol Oncol; 2021 Apr; 14(1):54. PubMed ID: 33794982
[TBL] [Abstract][Full Text] [Related]
15. Nanog RNA-binding proteins YBX1 and ILF3 affect pluripotency of embryonic stem cells.
Guo C; Xue Y; Yang G; Yin S; Shi W; Cheng Y; Yan X; Fan S; Zhang H; Zeng F
Cell Biol Int; 2016 Aug; 40(8):847-60. PubMed ID: 26289635
[TBL] [Abstract][Full Text] [Related]
16. Minihelix-containing RNAs mediate exportin-5-dependent nuclear export of the double-stranded RNA-binding protein ILF3.
Gwizdek C; Ossareh-Nazari B; Brownawell AM; Evers S; Macara IG; Dargemont C
J Biol Chem; 2004 Jan; 279(2):884-91. PubMed ID: 14570900
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation.
Jia R; Ajiro M; Yu L; McCoy P; Zheng ZM
RNA; 2019 May; 25(5):630-644. PubMed ID: 30796096
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of interleukin enhancer binding factor 3 (Ilf3) and nuclear factor 90 (NF90) interactome.
Chaumet A; Castella S; Gasmi L; Fradin A; Clodic G; Bolbach G; Poulhe R; Denoulet P; Larcher JC
Biochimie; 2013 Jun; 95(6):1146-57. PubMed ID: 23321469
[TBL] [Abstract][Full Text] [Related]
19. Interleukin enhancement binding factor 3 inhibits cardiac hypertrophy by targeting asymmetric dimethylarginine-nitric oxide.
Yang RH; Tan X; Ge LJ; Sun JC; Peng XD; Wang WZ
Nitric Oxide; 2019 Dec; 93():44-52. PubMed ID: 31536826
[TBL] [Abstract][Full Text] [Related]
20. Silencing of Transient Receptor Potential Channel 4 Alleviates oxLDL-induced Angiogenesis in Human Coronary Artery Endothelial Cells by Inhibition of VEGF and NF-κB.
Qin W; Xie W; Xia N; He Q; Sun T
Med Sci Monit; 2016 Mar; 22():930-6. PubMed ID: 26999308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
